Literature DB >> 9181305

Amount of the two major Ag-NOR proteins, nucleolin, and protein B23 is cell-cycle dependent.

V Sirri1, P Roussel, M C Gendron, D Hernandez-Verdun.   

Abstract

To know the biological basis allowing the use of Ag-NOR protein expression as proliferation marker in human malignancies, the relationship between cell cycle and amount of Ag-NOR protein was analyzed. The quantification of the two major Ag-NOR proteins, nucleolin and protein B23, was performed in exponentially growing, serum-deprived, and cell-cycle stimulated cells. Expression of nucleolin was low in serum-deprived cells and increased mostly in S phase during cell-cycle stimulation. Conversely, expression of protein B23 was slightly repressed in serum-deprived cells, and increased progressively until G2 phase during cell-cycle stimulation. The accumulation of nucleolin and protein B23 in G2 compared to G1 was demonstrated using sorted phase-specific cells. In G0, cells sorted according to their very low RNA content, and the amount of Ag-NOR proteins was half of that found in G1 cells, nucleolin being only weakly detectable. Therefore, the expression of nucleolin increased between G0-G1 and G1-S phases. These data support the hypothesis that quantification of Ag-NOR proteins is an estimation of the percentage of cells in each cell cycle phase because their amount is high in S-G2 and low in G1 phases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9181305

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  19 in total

1.  Adenovirus protein V induces redistribution of nucleolin and B23 from nucleolus to cytoplasm.

Authors:  D A Matthews
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  The nucleolar structure and the activity of NopA100, a nucleolin-like protein, during the cell cycle in proliferating plant cells.

Authors:  Fernando González-Camacho; Francisco Javier Medina
Journal:  Histochem Cell Biol       Date:  2005-10-11       Impact factor: 4.304

3.  Nucleolar function and size in cancer cells.

Authors:  M Derenzini; D Trerè; A Pession; L Montanaro; V Sirri; R L Ochs
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  Specific domains of nucleolin interact with Hdm2 and antagonize Hdm2-mediated p53 ubiquitination.

Authors:  Purvi Bhatt; Claire d'Avout; Naomi S Kane; James A Borowiec; Anjana Saxena
Journal:  FEBS J       Date:  2011-12-19       Impact factor: 5.542

5.  Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis.

Authors:  P J Greasley; C Bonnard; B Amati
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

6.  Interaction of the coronavirus nucleoprotein with nucleolar antigens and the host cell.

Authors:  Hongying Chen; Torsten Wurm; Paul Britton; Gavin Brooks; Julian A Hiscox
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals.

Authors:  M Paiardini; D Galati; B Cervasi; G Cannavo; L Galluzzi; M Montroni; D Guetard; M Magnani; G Piedimonte; G Silvestri
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  The requirement of c-Jun N-terminal kinase 2 in regulation of hypoxia-inducing factor-1α mRNA stability.

Authors:  Dongyun Zhang; Jingxia Li; Min Zhang; Guangxun Gao; Zhenghong Zuo; Yonghui Yu; Linda Zhu; Jimin Gao; Chuanshu Huang
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

9.  Osteopontin is histochemically detected by the AgNOR acid-silver staining.

Authors:  C Gaudin-Audrain; Y Gallois; F Pascaretti-Grizon; L Hubert; P Massin; M-F Baslé; D Chappard
Journal:  Histol Histopathol       Date:  2008-04       Impact factor: 2.303

10.  Nucleolin is required for an efficient herpes simplex virus type 1 infection.

Authors:  Aleth Callé; Iva Ugrinova; Alberto L Epstein; Philippe Bouvet; Jean-Jacques Diaz; Anna Greco
Journal:  J Virol       Date:  2008-03-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.